Life Sciences

Leahy aims to reverse USPTO’s discretionary denials in new PTAB reform bill

It is unclear whether the legislation will muster the level of support in Congress to make it onto the statute books

Leahy aims to reverse USPTO’s discretionary denials in new PTAB reform bill
NPE litigation in the US bounces back
22 Sep 2021

NPE litigation in the US bounces back

The Long Read: Sector-by-sector analysis reveals that transport, financial services and networking all recorded triple-digit percentage growth in patent suits filed by non-practising entities between 2018 and 2020, writes IAM data reporter Bridget Diakun

FDA seeks USPTO action to tackle patent thicketing
21 Sep 2021

FDA seeks USPTO action to tackle patent thicketing

IP policies proposed by the Department of Health miss the mark, but discussions between the two agencies get closer to the nub of the issue

Latest

View all
17 Sep 2021

Bausch Health pays $300 million to settle pay-for-delay class action

The agreement demonstrates the huge sums at stake in reverse payment disputes Read more

16 Sep 2021

CAFC decision highlights continued danger of inequitable conduct rulings

The Federal Circuit’s judgment in a recent pharma patent case is a stark reminder that IP professionals must remain vigilant Read more

14 Sep 2021

$8 billion Sobi takeover shows orphan drug IP assets are in high demand

The acquisition of the rare disease specialist is latest development in the booming orphan drug deals market Read more

14 Sep 2021

New Humira decision changes venue selection playbook for US biosimilar patent disputes

A recent court ruling suggests that plaintiffs will enjoy more latitude on venue selection when suing biologics imitators Read more

News

View all
11 Sep 2021

The DABUS decision makes Australia look like a champion of innovation, not a chump

Saturday Opinion: Federal Court's AI inventorship decision should serve as a clarion call for Australia to lead on innovation issues Read more

25 Aug 2021

IAM parent company acquires market-leading US patent litigation data and analytics firm

Austin-based Docket Navigator - which also covers trademarks, antitrust and other practice areas - becomes a Law Business Research company Read more

14 Jul 2021

Arthrex could offer life sciences patents extra layer of protection

Co-published - An additional level of scrutiny for IPR decisions will be a boon for owners of valuable pharma and biotech patents Read more

26 Jun 2021

For India and other countries, an IP waiver is a distraction not a solution to the covid-19 vaccine crisis

A TRIPs suspension will not provide the shot in the arm that millions of Indians need, but the country does have a major role to play in supplying vaccines to the world Read more

Analysis

View all
9 Sep 2021

Biologics patent thicketing problem getting worse, says Fresenius’ IP chief

The growing IP estates of new drugs such as Keytruda give an idea of the mounting challenges for US biosimilars, claims Rachel Moodie Read more

7 Sep 2021

English Court of Appeal brings sufficiency test into line with EPO case law

A recent UK judgment is good news for owners of patents claiming large numbers of compounds Read more

7 Sep 2021

Pfizer: light on patent filings and heavy on abandonments

An IP purge between 2011 and 2015 saw the lapse of many of the rights the pharma giant developed itself, as well as a number of those it had acquired Read more

3 Sep 2021

Bolsonaro vetoes Brazil’s first-of-a-kind compulsory tech transfer law

The president’s rejection of forced know-how licensing will now be reviewed by the country’s Congress, but a new patent suspension regime is set to come into force Read more

Insights

View all
12 Aug 2020

IP market news highlights

A rundown of some of the top news stories on the IAM platform in May, June and July Read more

12 Aug 2020

As the fallout from covid continues, the two IP superpowers offer different messages

While China cheers an uptick in applications, the USPTO warns of a prolonged downturn Read more

8 Jun 2020

IP Market news highlights

IAM’s biggest spring reads Read more

8 Jun 2020

From French fancy to global community – celebrating 100 issues of IAM 

Founder and editor in chief Joff Wild looks back on 17 years of IAM Read more